Jiewen Wang

1.1k total citations · 1 hit paper
31 papers, 757 citations indexed

About

Jiewen Wang is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jiewen Wang has authored 31 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jiewen Wang's work include Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer-related molecular mechanisms research (4 papers). Jiewen Wang is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer-related molecular mechanisms research (4 papers). Jiewen Wang collaborates with scholars based in China, Slovenia and Italy. Jiewen Wang's co-authors include Langxing Chen, Xiwen He, Yukui Zhang, Xihao Zhang, Guangbo Kang, He Huang, Ario de Marco, Mingjing Peng, Xianjie Jiang and Qianjin Liao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Jiewen Wang

29 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications

2025 36 citations Xianjie Jiang, Peng Qiu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiewen Wang China	16	383	165	104	102	79	31	757
Yixuan Xie United States	16	391 1.0×	34 0.2×	63 0.6×	56 0.5×	33 0.4×	57	711
Johannes Maier Germany	12	401 1.0×	186 1.1×	92 0.9×	43 0.4×	51 0.6×	19	608
É. M. Aizenshtein Israel	14	321 0.8×	48 0.3×	120 1.2×	69 0.7×	8 0.1×	63	723
Huimin Ge China	16	568 1.5×	73 0.4×	63 0.6×	94 0.9×	16 0.2×	46	1.1k
Wei Yin China	19	334 0.9×	18 0.1×	37 0.4×	88 0.9×	186 2.4×	41	879
Yuchen Han China	14	341 0.9×	24 0.1×	78 0.8×	48 0.5×	12 0.2×	56	750
Shuyan Yang China	13	211 0.6×	27 0.2×	22 0.2×	164 1.6×	27 0.3×	41	514
Yugang Guo China	14	456 1.2×	47 0.3×	381 3.7×	192 1.9×	142 1.8×	37	1.2k
Takuji Nakamura Japan	20	285 0.7×	19 0.1×	42 0.4×	41 0.4×	64 0.8×	81	1.5k

Countries citing papers authored by Jiewen Wang

Since Specialization

Citations

This map shows the geographic impact of Jiewen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewen Wang more than expected).

Fields of papers citing papers by Jiewen Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiewen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewen Wang. The network helps show where Jiewen Wang may publish in the future.

Co-authorship network of co-authors of Jiewen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiewen Wang. A scholar is included among the top collaborators of Jiewen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiewen Wang. Jiewen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Haoneng, Peng Qiu, Linda Oyang, et al.. (2025). Fusion genes in cancers: Biogenesis, functions, and therapeutic implications. Genes & Diseases. 12(5). 101536–101536.

Qiu, Peng, Xuemeng Xu, Wenlong Zhang, et al.. (2025). Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. International Journal of Biological Sciences. 21(7). 2991–3010. 3 indexed citations

Tan, Shiming, Shizhen Li, Longzheng Xia, et al.. (2025). Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway. International Journal of Oncology. 66(3). 1 indexed citations

Jiang, Xianjie, Peng Qiu, Linda Oyang, et al.. (2025). The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. Journal of Hematology & Oncology. 18(1). 40–40. 36 indexed citations breakdown →

Wang, Jiewen, Mingjing Peng, Linda Oyang, et al.. (2025). Mechanism and application of lactylation in cancers. Cell & Bioscience. 15(1). 76–76. 4 indexed citations

Jiang, Xianjie, Mingjing Peng, Qiang Liu, et al.. (2024). Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Molecular Cancer. 23(1). 151–151. 13 indexed citations

Wang, Jiewen, Guangbo Kang, Huiying Lu, et al.. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine. 14(3). e1636–e1636. 7 indexed citations

Xia, Longzheng, Jinguan Lin, Mingjing Peng, et al.. (2024). Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. International Journal of Biological Sciences. 20(4). 1125–1141. 8 indexed citations

Xu, Xuemeng, Qiu Peng, Xianjie Jiang, et al.. (2024). Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Communications. 44(11). 1316–1336. 39 indexed citations

10.

Li, Shizhen, Mingjing Peng, Shiming Tan, et al.. (2024). The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. Cancer Cell International. 24(1). 37–37. 15 indexed citations

11.

Wang, Jiewen, Nayiyuan Wu, Mingjing Peng, et al.. (2023). Ferritinophagy: research advance and clinical significance in cancers. Cell Death Discovery. 9(1). 463–463. 53 indexed citations

12.

Kang, Guangbo, Jiewen Wang, Shuxian Meng, et al.. (2023). Affinity maturation of antibody fragments: A review encompassing the development from random approaches to computational rational optimization. International Journal of Biological Macromolecules. 247. 125733–125733. 24 indexed citations

13.

Kang, Guangbo, Jiewen Wang, Xingjie Gao, et al.. (2022). Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies. Biomedicine & Pharmacotherapy. 158. 114174–114174. 20 indexed citations

14.

Wang, Jiewen, Ping Wang, Miao Zhang, et al.. (2022). Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations. Computational and Structural Biotechnology Journal. 21. 601–613. 14 indexed citations

15.

Soler, Miguel A., Jiewen Wang, Sandra Oloketuyi, et al.. (2021). Effect of Humanizing Mutations on the Stability of the Llama Single-Domain Variable Region. Biomolecules. 11(2). 163–163. 20 indexed citations

16.

Hu, Xiao, Hui Liu, Jie Li, Jiewen Wang, & Wenfang Peng. (2021). Protein macrocyclization by a recombinant asparaginyl endopeptidase. Acta Biochimica et Biophysica Sinica. 53(11). 1567–1570. 1 indexed citations

17.

Kang, Guangbo, Min Hu, He Ren, et al.. (2021). VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer <i>in vivo</i>. Cancer Biology and Medicine. 18(3). 772–787. 15 indexed citations

18.

Liu, Xiaohui, et al.. (2021). Modeling the effect of age on quantiles of the incubation period distribution of COVID-19. BMC Public Health. 21(1). 1762–1762.

19.

Hu, Min, Guangbo Kang, Xin Cheng, et al.. (2020). In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabody. Biochemical and Biophysical Research Communications. 529(4). 936–942. 17 indexed citations

20.

Wang, Jiewen, Shanshan Chen, Jian Guan, et al.. (2019). Anti-inflammatory and analgesic activity based on polymorphism of cedrol in mice. Environmental Toxicology and Pharmacology. 68. 13–18. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact